Forte Biosciences FBRX Stock
Forte Biosciences Price Chart
Forte Biosciences FBRX Financial and Trading Overview
| Forte Biosciences stock price | 76.99 USD |
| Previous Close | 76.99 USD |
| Open | 76.97 USD |
| Bid | 76.99 USD x 4200 |
| Ask | 98.52 USD x 200 |
| Day's Range | 76.96 - 77 USD |
| 52 Week Range | 10.11 - 77.2 USD |
| Volume | 1.4M USD |
| Avg. Volume | 1.36M USD |
| Market Cap | 1.63B USD |
| Beta (5Y Monthly) | 2.645 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.57 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 73 USD |
FBRX Valuation Measures
| Enterprise Value | 1.74B USD |
| Trailing P/E | N/A |
| Forward P/E | -18.893251 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 10.238031 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -18.376 |
Trading Information
Forte Biosciences Stock Price History
| Beta (5Y Monthly) | 2.645 |
| 52-Week Change | 596.74% |
| S&P500 52-Week Change | 19.80% |
| 52 Week High | 77.2 USD |
| 52 Week Low | 10.11 USD |
| 50-Day Moving Average | 55.18 USD |
| 200-Day Moving Average | 33.25 USD |
FBRX Share Statistics
| Avg. Volume (3 month) | 1.36M USD |
| Avg. Daily Volume (10-Days) | 1.69M USD |
| Shares Outstanding | 21.23M |
| Float | 18.67M |
| Short Ratio | 0.82 |
| % Held by Insiders | 1.64% |
| % Held by Institutions | 96.65% |
| Shares Short | 1.63M |
| Short % of Float | 7.73% |
| Short % of Shares Outstanding | 7.68% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -37.79% |
| Return on Equity (ttm) | -62.27% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -94721000 USD |
| Net Income Avi to Common (ttm) | -87937000 USD |
| Diluted EPS (ttm) | -4.57 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 198.46M USD |
| Total Cash Per Share (mrq) | 7.88 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 10.01 |
| Book Value Per Share (mrq) | 7.52 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -71976000 USD |
| Levered Free Cash Flow (ttm) | -41293500 USD |
Profile of Forte Biosciences
| Country | United States |
| State | TX |
| City | Dallas |
| Address | 3060 Pegasus Park Drive |
| ZIP | 75247 |
| Phone | 310 618 6994 |
| Website | https://www.fortebiorx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 23 |
Forte Biosciences, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for autoimmune and autoimmune-related diseases. The company offers products, such as its lead product candidate FB102, a proprietary molecule with applications for celiac disease, vitiligo, and alopecia areata; and services, including the clinical development and management of its Phase 2 clinical trials. Forte Biosciences, Inc. was incorporated in 2007 and is based in Dallas, Texas. As of August 27, 2026, Forte Biosciences, Inc. operates as a subsidiary of argenx SE.
Q&A For Forte Biosciences Stock
What is a current FBRX stock price?
Forte Biosciences FBRX stock price today per share is 76.99 USD.
How to purchase Forte Biosciences stock?
You can buy FBRX shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Forte Biosciences?
The stock symbol or ticker of Forte Biosciences is FBRX.
Which industry does the Forte Biosciences company belong to?
The Forte Biosciences industry is Biotechnology.
How many shares does Forte Biosciences have in circulation?
The max supply of Forte Biosciences shares is 21.23M.
What is Forte Biosciences Price to Earnings Ratio (PE Ratio)?
Forte Biosciences PE Ratio is now.
What was Forte Biosciences earnings per share over the trailing 12 months (TTM)?
Forte Biosciences EPS is -4.57 USD over the trailing 12 months.
Which sector does the Forte Biosciences company belong to?
The Forte Biosciences sector is Healthcare.
Forte Biosciences FBRX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26099.77 USD — |
-1.03
|
5.7B USD — | 25995.53 USD — | 26260.68 USD — | — - | 5.7B USD — |
|
US Tech Health Care
IXHC
US
|
1346.8 USD — |
+0.49
|
— — | 1335.94 USD — | 1347.07 USD — | — - | — — |
- {{ link.label }} {{link}}
